Intuniv Buyers Fight Actavis Bid To Nix Pay-For-Delay Suit
Direct purchasers of the attention deficit hyperactivity disorder medication Intuniv on Wednesday urged a Massachusetts federal court not to dismiss their antitrust case against Actavis LLC and Shire LLC, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article